JP MORGAN/PUT/INTUITIVE SURGICAL/320/0.01/19.07.24 Stock

Warrant

DE000JB8AYW4

Delayed Börse Stuttgart 05:16:06 2024-07-01 EDT
0.001 EUR 0.00% Intraday chart for JP MORGAN/PUT/INTUITIVE SURGICAL/320/0.01/19.07.24
3 months-97.22%
6 months-99.50%
Date Price Change
24-07-01 0.001 0.00%
24-06-28 0.001 0.00%
24-06-27 0.001 0.00%
24-06-25 0.001 0.00%

Delayed Quote Börse Stuttgart

Last update July 01, 2024 at 05:16 am

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying INTUITIVE SURGICAL, INC.
Issuer J.P. Morgan
WKN JB8AYW
ISINDE000JB8AYW4
Date issued 2023-11-27
Strike 320 $
Maturity 2024-07-19 (17 Days)
Parity 100 : 1
Emission price 0.28
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.3
Lowest since issue 0.001
Delta-0.03x
Omega 14.09
Premium26.85x
Gearing478.7x
Moneyness 0.7335
Difference Strike -118.8 $
Difference Strike %-37.13%
Spread 0.015
Spread %93.75%
Theoretical value 0.008500
Implied Volatility 80.26 %
Total Loss Probability 95.70 %
Intrinsic value 0.000000
Present value 0.008500
Break even 319.09 €
Theta-0.01x
Vega0x
Rho-0x

Company Profile

Intuitive Surgical, Inc. specializes in the design, manufacturing, and marketing of robotic surgical assistance video systems. The systems consist of a surgical console, arm, remote-controlled endoscope, and 3D visual immersion system. Net sales break down by activity as follows: - sale of instruments and accessories (60%): primarily wrist cuffs; - sale of robotic systems (23.6%): systems marketed under the da Vinci brand (1,370 units sold in 2023) and intended primarily for urological, cardio-thoracic, and gynecological surgeries; - installation and training services (16.4%). The United States accounts for 65.8% of net sales.
Sector
-
More about the company

Ratings for Intuitive Surgical, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Intuitive Surgical, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
438.8 USD
Average target price
428.1 USD
Spread / Average Target
-2.44%
Consensus